What role does Cardio Risk Check play in Langlebigkeit?

The Cardio Risk Check by MyBody-X is a direct-to-consumer DNA test that analyzes genetic variants associated with cardiovascular risk factors such as blood pressure, lipid metabolism, or inflammatory responses. In longevity research, cardiovascular health is paramount because heart disease remains the leading cause of death worldwide. However, the test's role in predicting individual lifespan is limited. Genetics contributes only a fraction to overall cardiovascular risk; lifestyle, diet, exercise, environment, and clinical biomarkers (e.g., cholesterol, blood pressure) are far stronger predictors. The provided context contains no specific studies or validated cutoffs for the Cardio Risk Check. A commentary on DTC genetics (PMID:22093530) highlights that such tests carry more risks than opportunities when used without clinical context. Therefore, the evidence for a direct role in longevity is rated as 'marketing/unclear'. The test may serve as a supplementary insight, but it does not replace a physician's risk assessment. A high genetic risk score should motivate preventive actions, not cause alarm. Without integration into a comprehensive health plan, its contribution to longevity remains speculative.